Calcipotriol, a derivative of vitamin D3, is a first-line therapeutic against psoriasis and inhibits psoriasis-like angiogenic features by suppressing VEGF, increasing PEDF and decreasing microvessel density (MVD) [20]. This evidence concerns the gene VEGFA and psoriasis.